Investing Profile

Kazumi Shiosaki

VC
Photo of Kazumi Shiosaki, Managing Partner at MPM Capital
UC Berkeley Network
43 CONNECTIONS
cb
MPM Capital Managing Partner
4
$100M
CompanyStageDateRound SizeTotal Raised
Twentyeight-Seven Therapeutics
Series AMay 2019$15M
Series ASep 2018$65M
Series AApr 2016
$80M
Co-investors: Michal Silverberg (Novartis Venture Fund), Henrijette Richter (Soffinova Partners)
Epizyme
Series BOct 2009$32M
$45M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds), Beth Seidenberg (Westlake Village BioPartners), David Mott (Mott Family Capital)
Managing Director MPM CapitalPresent
CEO Epizyme2007 - 2010
CEO Primera2004 - 2006
SVP Drug Discovery Millennium Pharmaceuticals1997 - 2001
UC Berkeley PhD Synthetic Chemistry